21/05/26

De Brauw x hollandbio: Scaling Beyond Series C

Late-stage biotech companies (Series C/D and beyond) face fundamentally different challenges compared to early-stage biotech ventures. Funding rounds become larger and more complex, investors apply stricter requirements, and governance and cross-border considerations carry greater weight.

Access to growth capital is not only crucial for biotech companies to grow and expand, but also helps strengthen the funding environment for and is essential to maintain the Netherlands’ international competitive position.

During this event, we bring together strategic insights from investors, bankers, and lawyers, share company perspectives on late-stage financing options, and inform you about different strategies to attract growth capital.

Program

15:30 – Walk in with coffee and tea

16:00 – Start program including setting the scene, panel discussion with an investor, banker and lawyer, and a fireside chat with companies

17:00 – Networking drinks

This event will take place on May 21 at the Amsterdam office of De Brauw Blackstone Westbroek. Visiting address: Burgerweeshuispad 201, 1076 GR Amsterdam

Please register via the online form.

door Idalia Dlugosz